4,0
7. Juli 2013
Aktueller Mitarbeiter, mehr als 3 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
- Decent Pay - Sales meetings are fun and exciting - Self management/Little micromanaging (depending on manager) - Great products and a respected name - Good availability and access of doctors
Kontras
- Too much change industry-wide - Too much change within the company with the Novartis merger - Must be willing to relocate to be promoted - Some travel